Papillary Muscle Dysfunction: Understanding Heart Function Impairment

what is papillary muscle dysfunction

Papillary muscle dysfunction is a cardiac condition that can lead to serious complications, including heart failure. It is characterised by the regurgitation of blood through the valves, causing a backflow that impacts the left or right side of the heart. This dysfunction is often associated with mitral valve issues and can be caused by various factors such as ischemia, infarction, ventricular dilatation, rupture, inflammatory disease, and interventricular conduction disturbances. The syndrome of papillary muscle dysfunction was first introduced in 1963, and since then, it has gained attention in the medical field, with ongoing discussions about the best treatment approaches.

Characteristics Values
Cause Myocardial ischemia, trauma, or infective endocarditis
Function Restrain the mitral valves
Complications Severe left ventricular dysfunction, pulmonary edema, decreased cardiac output, organ hypoperfusion, ventricular septal rupture, free-wall myocardial rupture
Treatment Mitral valve repair is preferred over replacement
Symptoms Murmers, ventricular aneurysm, systolic murmur, diastolic and presystolic gallops

cyvigor

Papillary muscle rupture

The heart contains five papillary muscles originating from the ventricular walls. These muscles attach to the tricuspid and mitral valve leaflets through the chordae tendineae, preventing ventricular blood regurgitation by stabilizing the valves during systole. Three papillary muscles—anterior, posterior, and septal—attach to the tricuspid valve, while two—anterolateral and posteromedial—connect to the mitral valve. The anterolateral and posteromedial papillary muscles play a key role in maintaining mitral valve function. The anterolateral muscle receives a dual blood supply, while the posteromedial muscle is supplied solely by the posterior descending coronary artery. Due to this single blood supply, the posteromedial papillary muscle is more likely to rupture following a myocardial infarction.

Rupture of the tricuspid papillary muscles can occur due to myocardial ischemia, trauma, or infective endocarditis. Papillary muscle rupture leads to severe mitral valve regurgitation, often resulting in cardiogenic shock and pulmonary edema, necessitating immediate medical intervention. It is usually fatal and refractory to medical treatment, and urgent mitral valve replacement is required to correct the hemodynamic deterioration of the patient.

Other complications of myocardial infarction that may present similarly to papillary muscle rupture include cardiogenic shock due to severe left and right ventricular dysfunction, ventricular septal rupture, and free-wall myocardial rupture.

cyvigor

Mitral regurgitation

Papillary muscle dysfunction can cause blood to regurgitate through the valves, leading to a backflow of blood that can result in left- or right-sided heart failure. Mitral regurgitation is a heart condition characterised by the leakage of blood backward through the mitral valve each time the left ventricle contracts. This leakage allows blood to flow in two directions during contraction. Some blood flows from the left ventricle through the aortic valve, as it should, but some flows back into the left atrium. This leakage can increase blood volume and pressure in the left atrium, which can in turn increase pressure in the pulmonary veins. If regurgitation is severe, this increased pressure may result in congestion or fluid buildup in the lungs.

Mild mitral regurgitation often has no symptoms, but when they do occur, they may include coughing, exhaustion, lightheadedness, increased urination at night, rapid breathing, or palpitations. Mitral regurgitation is the most common valvular abnormality worldwide, affecting over 2% of the total population, and its prevalence increases with age. It has various causes, including congenital conditions, rheumatic fever, and degenerative changes in the valve.

The Carpentier Classification divides mitral regurgitation into three types based on leaflet motion: degenerative, functional, and others. Degenerative mitral regurgitation is most commonly related to myxomatous degeneration of the mitral valve, resulting in mitral valve prolapse (MVP). MVP can occur as a primary, non-syndromic disease driven by advancing age, or as a secondary, syndromic process caused by connective tissue diseases. Functional mitral regurgitation is caused by changes in the left ventricle's size or shape, impairing the coaptation of the mitral leaflets.

cyvigor

Ventricular dysfunction

The heart contains five papillary muscles originating from the ventricular walls. These muscles attach to the tricuspid and mitral valve leaflets, preventing ventricular blood regurgitation by stabilising the valves during systole. Papillary muscle dysfunction causes blood to regurgitate through the valves, leading to a backflow of blood that can result in left- or right-sided heart failure.

Left ventricular dysfunction, or left heart failure, occurs when there is a dysfunction of the left ventricle, resulting in insufficient delivery of blood to vital organs. This can lead to serious complications such as pulmonary edema and decreased cardiac output, ultimately resulting in organ hypoperfusion. Risk factors for left ventricular dysfunction include increasing age, diabetes, high blood pressure, and certain medications. It is a potentially fatal condition that can go unnoticed without any symptoms.

Right ventricular dysfunction presents with elevated jugular venous pressure, peripheral edema, hypotension, and clear lung fields. Right ventricular failure may also result in underfilling the left heart chambers, resulting in a low cardiac output state. Severe right ventricular dysfunction can lead to cardiogenic shock due to severe left and right ventricular failure, ventricular septal rupture, and free-wall myocardial rupture.

Papillary muscle dysfunction can lead to mitral regurgitation, which can be caused by coronary artery spasm or ischemic mitral regurgitation. Mitral valve repair is the preferred surgical procedure for treating ischemic mitral regurgitation, unless necrotic papillary muscle tissue is present.

cyvigor

Coronary artery disease

Papillary muscle dysfunction is a common accompaniment of coronary artery disease. It is a syndrome that was first described in 1963 and is characterised by the regurgitation of blood through the valves, leading to a backflow of blood that can result in left- or right-sided heart failure. The papillary muscles restrain the mitral valves, and dysfunction can occur when there is an inadequate blood supply to these structures. This can be caused by coronary artery spasms or coronary atherosclerosis, which is the most common cause of papillary muscle fibrosis/necrosis without rupture.

Mitral regurgitation is a common complication of papillary muscle dysfunction. This can be caused by fibrosis of the free wall beneath the papillary muscle, which impairs left ventricular contraction. Ventricular aneurysm is another frequent complication. In advanced cases, surgical therapy may be indicated if congestive heart failure results from severe mitral regurgitation or ventricular aneurysm associated with papillary muscle dysfunction.

The treatment of papillary muscle dysfunction and associated mitral regurgitation is a matter of controversy. Mitral valve repair is currently preferred over valve replacement unless necrotic papillary muscle tissue is present. Concomitant coronary artery bypass has been shown to improve outcomes. However, suboptimal outcomes following valve repair have been linked to prolonged cross-clamp times, suturing into friable necrotic tissue, and tissue remodelling after infarction. Surgeons may delay the repair of partial papillary muscle rupture to allow tissue necrosis to resolve, but this decision depends on the patient's stability and may require earlier surgical correction.

cyvigor

Mitral valve repair

Papillary muscle dysfunction is a rare but potentially fatal complication that occurs after myocardial infarction or due to infective endocarditis. It is caused by inadequate blood supply to the papillary muscles, which can lead to a transient murmur. The papillary muscles play a crucial role in restraining the mitral valves, preventing ventricular blood regurgitation and stabilising the valves during systole.

The mitral valve repair procedure involves stabilising the partially torn papillary muscle and reducing mitral regurgitation. This can be achieved through techniques such as the MitraClip system, which employs a zipper approach with multiple clips to reduce regurgitation and improve left atrial pressure.

While mitral valve repair is necessary for patients with severe mitral regurgitation, it is not a perfect solution. The repair carries a significant risk of mortality, especially in patients with advanced age or severe comorbidities. Early detection and rapid intervention are crucial for improving survival rates, but long-term prognosis depends on the extent of left ventricular damage and overall patient health.

Muscling Drugs: What Does It Mean?

You may want to see also

Frequently asked questions

Papillary muscle dysfunction is a common accompaniment of coronary artery disease. It is caused by the transient inadequacy of blood supply to the papillary muscles.

Papillary muscle dysfunction results in mitral regurgitation and an apical systolic murmur. It can lead to backflow of blood, causing left- or right-sided heart failure.

Papillary muscle dysfunction may occur as a result of ischemia or infarction of a papillary muscle, ventricular dilatation, rupture of a papillary muscle, inflammatory disease of a papillary muscle, or interventricular conduction disturbances.

The treatment for papillary muscle dysfunction is surgical. Mitral valve repair is preferred over valve replacement unless necrotic papillary muscle tissue is present.

Written by
Reviewed by
Share this post
Print
Did this article help you?

Leave a comment